The influence of age on immunity to infection with Mycobacterium tuberculosis

Immunological Reviews

Volumn 205, Issue , 2005, Pages 229-243

  Vesosky, Bridget ^a   Turner, Joanne ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADOLESCENT; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EFFECTOR CELL; INFECTION RESISTANCE; INFECTION SENSITIVITY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TUBERCULOSIS;

AGING; ANIMALS; DISEASE SUSCEPTIBILITY; HUMANS; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 20344397910     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2005.00257.x     Document Type: Review

References (92)

1. Webster RG. Immunity to influenza in the elderly. Vaccine 2000;18:1686-1689.
2. Esposito A. Pneumonia in the elderly. Am Fam Physicians 1989;40:23S-32S.
3. Stein BE. Vaccinating elderly people. Drugs Aging 1994;5:242-253.
4. Jernigan JA, et al. Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States. Emerg Infect Dis 2001;7:933.
5. MMWR. Provisional surveillance summary of the West Nile virus epidemic - United States, January-November 2002. MMWR 2002;51:1129.
6. WHO. Consensus Document on the Epidemiology of Severe Acute Respiratory Syndrome (SARS). WHO Department of communicable disease surveillance and response epidemic and alert response 2003. Available at http://www.WHO/CDS/CSR/ GAR/2003.11.
7. Beers MH, Berkow R. The Merck manual of geriatrics. Merck Research Laboratories, Whitehouse Station, NJ, 2000.
8. Brooks JV, Frank AA, Keen MA, Belisle JT, Orme IM. Boosting vaccine for tuberculosis. Infect Immun 2001;69:2714-2717.
9. American Lung Association. Trends in tuberculosis morbidity and mortality. Available at http://www.lungusa.org, 2003.
10. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organisation. Tuberculosis 1991;72:1-6.
11. Gubser VL. Tuberculosis in the elderly. A community perspective. J Gerontol Nurs 1998;24:36-41.
12. Dutt AK. Tuberculosis. Clin Ger Med 1992;8:761-775.
13. Mackay AD, Cole RB. The problems of tuberculosis in the elderly. Q J Med 1984;212:497-510.
14. Rich AR. The pathogenesis of tuberculosis. Springfield, IL: Charles C. Thomas Co., 1951.
15. Globerson A, Effros RB. Ageing of lymphocytes and lymphocytes in the aged. Immunol Today 2000;21:467-527.
16. Stead WW, Dutt AK. Tuberculosis in elderly persons. Ann Rev Med 1991;42:267-276.
17. Steimke EH, Tenholder MF, McCormick MI, Rissing JP. Tuberculosis surveillance: Lessons from a cluster of skin test conversions. Am J Infect Cont 1993;21:236-241.
18. Gubser VL. Tuberculosis in the elderly. A community health perspective. J Gerontol Nurs 1998;24:36-41.
19. Flynn JL, Chan J. Immunology of tuberculosis. Ann Rev Immunol 2001;19:93-129.
20. Newport MJ, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Eng J Med 1996;335:1941-1949.
21. Altare F, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998;280:1432-1435.
22. Keane J, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Eng J Med 2001;345:1098-1104.
23. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon γ gene-disrupted mice. J Exp Immunol 1993;178:2243-2247.
24. Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, Orme IM. The role of interleukin-12 acquired immunity to Mycobacterium tuberculosis infection. Immunol 1995;84:423-432.
25. Flynn J, Goldstein MM, Tribold KJ, Sypek J, Wolf S, Bloom BR. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol 1995;155:2515-2524.
26. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-2254.
27. Flynn JL, et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995;2:561-572.
28. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med 2001;193:271-280.
29. + T-cell subsets that mediate immunological memory to Mycobacterium tuberculosis infection in mice. Infect Immun 2000;68:621-629.
30. Turner J, et al. CD8- and CD95/951-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis. Am J Respir Cell Mol Biol 2001;24: 203-209.
31. Serbina NV, Flynn JL. Early emergence of CD8 (+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect Immun 1999;67:3980-3988.
32. Orme IM. Aging and immunity to tuberculosis: Increased susceptibility of old mice reflects a decreased capacity to generate mediator T lymphocytes. J Immunol 1987;138:4414-4418.
33. Cardona PJ, et al. The intravenous model of murine tuberculosis is less pathogenic than the aerogenic model owing to a more rapid induction of systemic immunity. Scand J Immunol 1999;49:362-366.
34. Cooper AM, Callahan JE, Griffin JP, Roberts AD, Orme IM. Old mice are able to control low-dose aerogenic infections with Mycobacterium tuberculosis. Infect Immun 1995;63:3259-3265.
35. Junqueira-Kipnis AP, Turner J, Gonzalez-Juarrero M, Turner OC, Orme IM. Stable T-cell population expressing an effector cell surface phenotype in the lungs of mice chronically infected with Mycobacterium tuberculosis. Infect Immun 2004;72:570-575.
36. Orme IM. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol 1987;138:293-298.
37. Turner J, Frank AA, Orme IM. Old mice express a transient early resistance to pulmonary tuberculosis that is mediated by CD8 T cells. Infect Immun 2001;70: 4628-4637.
38. Orme IM, Griffin JP, Roberts AD, Ernst DN. Evidence for a defective accumulation of protective T cells in old mice infected with Mycobacterium tuberculosis. Cell Immunol 1993;147:222-229.
39. Turner J, Frank AA, Brooks JV, Marietta PM, Vesosky B, Orme IM. Tuberculosis in aged γδ T cell gene disrupted mice. Exp Gerontol 2001;36:245-254.
40. Turner J, Orme IM. Identification of altered integrin α/β chain expression on T cells from old mice infected with Mycobacterium tuberculosis. Exp Gerontol 2002;37:907-916.
41. + T cells from young and old mice. J Immunol 1990;145:1295-1302.
42. Miller RA. Age-related changes in T cell surface markers: a longitudinal analysis in genetically heterogeneous mice. Mech Ageing Dev 1997;96:181-196.
43. Orme IM, Roberts AD. Changes in integrin/adhesion molecule expression, but not in the T-cell receptor repertoire, in old mice infected with tuberculosis. Mech Ageing Dev 1998;105:19-29.
44. Turner J, et al. A limited antigen-specific cellular response is sufficient for the early control of Mycobacterium tuberculosis in the lung but is insufficient for long-term survival. Infect Immun 2004;72:3759-3768.
45. Fernandez-Gutierrez B, et al. Early lymphocyte activation in elderly humans: Impaired T and T-dependent B cell responses. Exp Geront 1999;34:217-229.
46. Wikby A, Maxson P, Olsson J, Johansson B, Ferguson FG. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: The Swedish longitudinal octo-immune study. Mech Ageing Dev 1998;102:187-198.
47. Linton P-J, Haynes L, Klinman NR, Swain SL. Antigen-independent changes in naive CD4 T cells with aging. J Immunol 1996;184: 1891-1900.
48. Miller RA. Age-associated decline in precursor frequency for different T cell-mediated reactions, with preservation of helper or cytotoxic effect per precursor cell. J Immunol 1984;132:63-68.
49. Bruunsgaard H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK. Proliferative responses of blood mononuclear cells (BMNC) in a cohort of elderly humans: Role of lymphocyte phenotype and cytokine production. Clin Exp Immunol 2000;119:433-440.
50. Haynes L, Linton P-J, Eaton SM, Tonkonogy SL, Swain SL. Interleukin 2, but not other common γ chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med 1999;190:1013-1023.
51. Negoro S, et al. Mechanisms of age-related decline in antigen-specific T cell proliferation response: IL-2 receptor expression and recombinant IL-2 induced proliferative response of purified tac-positive T cells. Mech Ageing Dev 1986;36:223-241.
52. Krumpe PE, Knudson RJ, Parsons G, Reiser K. The aging respiratory system. Clin Geriatr Med 1985;1:143-175.
53. Meyer KC, Soergel P. Variation of brochoalveolar lymphocyte phenotypes with age in the physiologically normal human lung. Thorax 1999;54:697-700.
54. + T cells to the lung airways during respiratory virus infections. J Immunol 2003;170:1423-1429.
55. + T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol 2001;2:1067-1073.
56. Castle SC, Uyemura K, Crawford W, Wong W, Makinodan T. Antigen presenting cell function is enhanced in healthy elderly. Mech Ageing Dev 1999;107:137-145.
57. Roubenoff R, Harris TB, Abad LW, Wilson PWF, Dallal GE, Dinarello CA. Monocyte cytokine production in an elderly population: Effect of age and inflammation. J Gerontol A Biol Sci Med Sci 1998;53A:M20-M26.
58. Zissel G, Schlaak M, Muller-Quernheim J. Age-related decrease in accessory cell function of human alveolar macrophages. Acc Func Ageing 1999;47:51-56.
59. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Toll-like receptor expression and function in aging. J Immunol 2002;169:4697-4701.
60. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999;163:3920-3927.
61. Noss EH, et al. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 2001;167:910-918.
62. Fulton SA, et al. Inhibition of major histocompatibility complex class II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein. Infect Immun 2004;72:2101-2110.
63. Rhoades ER, Orme IM. Similar responses by macrophages from young and old mice infected with Mycobacterium tuberculosis. Mech Ageing Dev 1998;106:145-153.
64. D'Souza CD, Cooper AM, Frank AA, Mazzaccaro RJ, Bloom BR, Orme IM. An antiinflammatory role for γδ lymphocytes in acquired immunity to Mycobacterium tuberculosis. J Immunol 1997;158:1217-1221.
65. Boom WH, Chervenak KA, Mincek MA, Ellner JJ. Role of the mononuclear phagocyte as an antigen-presenting cell for human γδ cells activated by live Mycobacterium tuberculosis. Infect Immun 1992;60:3480-3488.
66. Janis EM, Kaufmann SHE, Schwartz RH, Pardoll DM. Activation of γδ cells in the primary immune response to Mycobacterium tuberculosis. Science 1989;244:713-716.
67. Holoshitz J, et al. MHC-independent presentation of mycobacteria to human γδ T cells. Int Immunol 1993;5:1437-1443.
68. Griffin JP, Harshan KV, Born WK, Orme IM. Kinetics of accumulation of γδ receptor-bearing T lymphocytes in mice infected with live mycobacteria. Infect Immun 1991;59:4263-4264.
69. D'Souza CD, et al. A novel nonclassical β2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung. Am J Respir Cell Mol Biol 2000;23:188-193.
70. van Pinxteren LA, Cassidy JP, Smedegaard BH, Agger EM, Andersen P. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol 2000;30:3689-3698.
71. + T cells participate in the memory immune response to Mycobacterium tuberculosis. Infect Immun 2001;69:4320-4328.
72. + CTL from lungs of Mycobacterium tuberculosis-infected mice express perform in vivo and lyse infected macrophages. J Immunol 2000;165:353-363.
73. Turner J, Orme IM. The expression of early resistance to an infection with Mycobacterium tuberculosis by old mice is dependent on IFN type II (IFN-γ) but not IFN type I. Mech Ageing Dev 2004;125:1-9.
74. Effros RB, Walford RL. Diminished T-cell response to influenza virus in aged mice. Immunol 1983;49:387-392.
75. Effros RB, Walford RL. The immune response of aged mice to influenza: Diminished T-cell proliferation, interleukin 2 production and cytotoxicity. Cell Immunol 1983;81: 298-305.
76. Solana R, Alonso MC, Pena J. Natural killer cells in healthy aging. Exp Gerontol 1999;34:435-443.
77. Griffin JP, Orme IM. Evolution of CD4 T-cell subsets following infection of naive and memory immune mice with Mycobacterium tuberculosis. Infect Immun 1994;62:1683-1690.
78. + T cells with intermediate TCR increasing with age provide a source of early IFN-γ production. J Immunol 2000;164:5652-5658.
79. + T cells contributes to the rapid production of IFN-γ in response to bacterial pathogens. J Immunol 2001;166:1097-1105.
80. + T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J Exp Med 2003;198:1583-1593.
81. + T cells to innate immunity; IFN-γ secretion induced by IL-12 and IL-18. Eur J Immunol 2002;32:2807-2816.
82. Otiz-Suarez A, Miller RA. A subset of CD8 memory T cells from old mice have high levels of CD28 and produce IFN-γ. Clin Immunol 2002;104:282-292.
83. + T cells in vivo by IL-15. Immunity 1998;8:591-599.
84. Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon. Science 1996;272:1947-1950.
85. + T cell turnover in vivo by IL-12, IL-18, and IFN-γ. J Immunol 2001;166:6007-6011.
86. + memory T cells by opposing cytokines. Science 2000;288:675-678.
87. Doherty TM, Seder RA, Sher A. Induction and regulation of IL-15 expression in murine macrophages. J Immunol 1996;156:735-741.
88. Umemura M, Nishimura H, Hirose K, Matsuguchi T, Yoshikai Y. Overexpression of IL-15 in vivo enhances protection against Mycobacterium bovis bacillus Calmette-Guerin infection via augmentation of NK and T cytotoxic 1 responses. J Immunol 2001;167:946-956.
89. Maeurer MJ, et al. Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice. Infect Immun 2000;68:2962-2970.
90. Cooper AM, Pearl JE, Brooks JV, Ehlers S, Orme IM. Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect Immun 2000;68: 6879-6882.
91. Giosue S, et al. Effects of aerosolized interferon-α in patients with pulmonary tuberculosis. Am J Respir Crit Care Med 1998;158:1156-1162.
92. Ranju B, et al. Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis. Infect Immun 2004;72:1275-1283.